Skip to main content

Animations

MJFF Publications

3081 - 3090 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Targeted copy number variant identification across the neurodegenerative disease spectrum
    Journal Name: Molecular Genetics & Genomic Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mgg3.1986
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Adenosine A2A Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28897
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28913
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15307
    Citation Count: 102
  • Summary Details
    OPEN
    Title: Path analysis of biomarkers for cognitive decline in early Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0268379
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00332-0
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00317-8
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.886575
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA gene
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03610-7
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.880583
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.